Editorial: ustekinumab during pregnancy-reassuring but still not enough. Authors' reply
Aliment Pharmacol Ther
.
2023 Jan;57(1):160.
doi: 10.1111/apt.17282.
Epub 2022 Dec 5.
Authors
Ariella Bar-Gil Shitrit
1
,
Irit Avni-Biron
2
Affiliations
1
IBD MOM Unit, Digestive Disease Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
2
IBD Center, Division of Gastroenterology, Rabin Medical Center, Petah-Tikva, Israel.
PMID:
36468216
DOI:
10.1111/apt.17282
No abstract available
Publication types
Editorial
Comment
MeSH terms
Female
Humans
Pregnancy
Ustekinumab* / therapeutic use
Substances
Ustekinumab